CalciMedica, Inc. (CALC) - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K, dated November 12, 2025, reports the issuance of a press release regarding financial results for the fiscal quarter ended September 30, 2025. CalciMedica, Inc. is a Delaware corporation with principal executive offices in La Jolla, California, and its common stock trades on The Nasdaq Capital Market under the symbol "CALC."
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The document serves as a notification that these results were announced via a press release attached as Exhibit 99.1, but the specific financial data points are not embedded within the body of this 8-K report.
Material Changes
No material changes versus the prior comparable period are detailed in the text of this filing. The report references the attached press release for the full disclosure of operational and financial performance for the quarter ended September 30, 2025.
Guidance, Outlook, and Risks
The filing does not contain specific management commentary, forward-looking guidance, risk factors, or contingencies within its text. It explicitly states that the information in Item 2.02 and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Exchange Act and shall not be incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review the attached Exhibit 99.1 (Press Release dated November 12, 2025) for actual revenue, net loss, and cash position figures.
- Verify the company's cash runway and burn rate as disclosed in the full press release.
- Check for any updates on clinical trial progress or regulatory milestones mentioned in the press release.
- Confirm the status of the company's emerging growth company election and any related accounting standard transitions.